| 
Results for genentech. Search took 0.05 seconds.
Install OS X On SD Card
in Wangtam, on June 30, 2009
...l Leave
• Facebook Selects New CFO: Former Genentech Exec Ebersman
• Nero 9.4.13.2b
• Dell Developing Pocket-Sized Device
• Desktop Media: get automatic desktop shortcuts when you plug in your...
The Cloud Is Coming - and With It, Change for Business
in Web 2.0, on June 21, 2009
...t entirely to cloud services, even using Facebook as its main source of internal communications. GENENTECH (DNA) has made medical experts available to sales reps in the field with a couple of butt...
Psoriasis Drug Raptiva Found Linked To Rare Brain Infection
in Straightfromthedoc, on February 21, 2009
...issued a public health advisory regarding the psoriasis drug Raptiva .
Raptiva - a product of Genentech - is once-weekly injection approved for adults with moderate to severe plaque psoriasis w...
Roche Made US$43.7B Bid For Remaining Genentech Shares
in The Biotech Weblog, on July 21, 2008
...f Genetech's outstanding shares. Now Roche has offered a bid of US$43.7 billion to the rest of Genentech that it doesn't own.
Genentech is a leading biotechnology company specializing in ...
Targeting p110delta Protein to Treat Asthma and Allergies
in Allergies, on February 16, 2008
...nes targeting this protein can block allergic reactions even before symptoms occur.
More recently, Genentech and Novartis AG have introduced a new medicine for severe asthma called Xolair that blocks...
Andrea Jung 进入 Apple 董事会
in M2 十字街口, on January 10, 2008
Ars Technica 消息 ，原雅芳公司主席兼 CEO Andrea Jung（钟彬娴）已经被选入 Apple 公司董事会。Jobs 似乎对这位女士相当具有信心，认为 Andrea Jung 的市场能力会为 Apple 带来新鲜血液。
Taxol+Avastin Greatly Slowed Progression of Breast Cancer
in Straightfromthedoc, on December 30, 2007
...y that acts to reduce the development of blood vessels that feed tumors - Avastin - a product of Genentech , has already been approved by the FDA for the treatment of colorectal and lung cancer.
...
Sanofi-Aventis Acquires 19% of Regeneron
in The Biotech Weblog, on November 30, 2007
...ept (VEGF Trap), a cancer drug in late-stage trials for prostate and lung cancer, an equivalent of Genentech's Avastin .
Source: Wall Street Journal ...
Pertuzumab Boosts Survival in Recurrent Ovarian Cancer Patients
in The Biotech Weblog, on September 28, 2007
... with stage 3 recurrent ovarian cancer .
Pertuzumab is a monoclonal antibody being developed by Genentech as a chemotherapeutic drug against prostate, breast, and ovarian cancers .
In the study,...
Efalizumab (Raptiva®), Safe and Effective in Treatment of Heavy Psoriasis Patients
in Straightfromthedoc, on August 6, 2007
... Marketed by Genentech as Raptiva® - Efalizumab - a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that l...
Cancer Drug Avastin® May Help Save Vision
in Straightfromthedoc, on June 26, 2007
... treated with radiation therapy and commonly develop radiation retinopathy."
A product of Genentech , Avastin® (bevacizumab) is the first US FDA-approved therapy designed to inhibit angiogen...
Xolair: Breakthrough Drug Against Allergic Asthma
in Allergies, on May 24, 2007
... administered in a doctor's clinic. A few months ago, the FDA also requested its manufacturer, Genentech, to add a boxed warning and strengthen its label warning on the packaging regarding the p...
Google Invests $39M in Biotech Start-up on Personal Genetics
in The Biotech Weblog, on May 24, 2007
...ture capital firms New Enterprise Associates and Mohr Davidow Ventures and biotechnology giant Genentech Inc. were among the investors in this initial round of outside funding. The terms of thes...
Google被美国《连线》杂志评为2007世界最创新企业 百度排第11位
in GSeeker, on March 29, 2007
美国《连线》杂志（ Wired ）公布了2007年度的" The Wired 40 "排行榜，评选出世界上最具创新力的40家企业。再一次，Google排在首位。Google在过去也曾多次入选该排行榜，并且位居第一。《连线》杂志认为Google正全力建设数据中心及全球化光纤网络，正在进行历史性的创新，而外界对于Google的影响力的敬畏及恐惧感也日益增长。Apple这次屈居亚军，入选的主要原因是iPhone等新产品的出现。
FDA Proposes to Strengthen Label Warning for Xolair
in Allergies, on February 26, 2007
... Fainting , itching and hives, and swelling of the mouth and throat. The FDA is now requesting Genentech, the manufacturer, to add a boxed warning to the product label .
Due to the nature of con...
Genentech Licenses BioInvent's Cardiovascular Drug Candidate
in The Biotech Weblog, on January 15, 2007
... Genentech, Inc . is paying an upfront payment of $15 million to co-develop and commercialize BioInvent ´s proprietary antibody candidate, BI-204 , for the potential treatment of multiple cardiov...
Big Biotech Stocks To Perform Better in 2007
in The Biotech Weblog, on January 12, 2007
...n't been a good year for biotech firms, but analysts say big biotech companies like Amgen , Genentech , Celgene and Gilead Sciences would perform better in 2007.
"We're looking f...
Top 20 Employers in the Biotech and Pharmaceutical Industries
in The Biotech Weblog, on October 23, 2006
... For the 5th time in a row, Genentech, Inc, of San Francisco, CA, has topped Science's survey of top employers in the biotechnology and pharmaceutical industries . The web-based survey was carr...
Morgan Stanley Expect Favorable Returns from Large Biotech Companies
in The Biotech Weblog, on July 20, 2006
...ious diseases, oncology and immunology : Flumist® , Synagis® , Ethyol® , Cytogam®
Genentech : Biopharma focusing on oncology, immunology, disorders of tissue growth and repair, including...
FDA Approves Lucentis For Age-Related Vision Loss
in The Biotech Weblog, on July 3, 2006
...
After a 6-month priority review, the U.S. Food and Drug Administration (FDA) has approved Genentech 's drug against age-related macular degeneration (AMD). LUCENTIS™ (ranibizumab) is...
Top 20 Molecular Millionaires
in The Biotech Weblog, on May 31, 2006
...o pursue biotech careers can wind up fabulously wealthy."
Heading of this year's pack is Genentech 's Chairman and CEO, Dr. Arthur Levinson (photo). Here's the full list, ranked acc...
Pfizer Acquires Rinat Neuroscience Corp.
in The Biotech Weblog, on April 13, 2006
... as it announces its plans to acquire Rinat Neuroscience Corp. , a privately held spin-off from Genentech , which develops treatments for diseases and disorders of the central nervous system.
&q...
Origene TrueClone™ Collection, Acquired By Genentech
in The Biotech Weblog, on April 3, 2006
... human full- length cDNA clones suitable for transfection and direct in vitro expression.
Genentech recently acquired this collection of clones that are expression-ready are authentic full-len...
Big Pharmaceuticals Expected to Repatriate $100B
in The Biotech Weblog, on February 21, 2006
...is fundamentally going to change and improve your pipeline prospects akin to what Roche did with Genentech , which is clearly the best investment of all time," he said. "They didn't b...
James D. Watson Helix Award for Biotechnology Industry Leadership
in The Biotech Weblog, on February 19, 2006
...f the James D. Watson Helix Award for Biotechnology Industry Leadership .
Large Capitalization : Genentech Inc., of South San Francisco, Calif.
Emerging Company/Mid-Capitalization : Alnylam Pharma...
avastin: promising but expensive cancer drug
in Straightfromthedoc, on February 17, 2006
...ent for lung and breast cancer too. However many are already cringing at the price that its maker, Genentech , plans to charge for it: about $100,000 a year; a price about double the current level as...
$200M Venture Capital For Emerging Public Health Risks
in The Biotech Weblog, on February 16, 2006
...l backing to some of the best known technology and biotech firms today, including Google Inc. , Genentech , Inc , Sun Microsystems, Inc , and Amazon.com Inc. .
This time, Kleiner aims its ...
Top Five Regions For Biotech Companies
in The Biotech Weblog, on January 26, 2006
...ia
California is building on one of the biggest life sciences bases in the world. Amgen and Genentech are just two of the biotech stars based in the state, and Stanford recently announced...
Will Biotech Be Good Bets in 2006?
in The Biotech Weblog, on January 6, 2006
...biotech will remain to be good bets, if the successes and potentials of companies such as Amgen and Genentech were to be based upon.
"These companies are Flush with new products and provi...
How cancer cells spread
in Straightfromthedoc, on December 8, 2005
...ing questions about what gives tumors the power to invade new tissues. Drugs such as Avastin from Genentech Inc. and Roche Holding AG that can slow blood vessel growth in existing cancers also ...
Seven Technologies That Change Everything
in Wangtam, on October 9, 2005
...atented drug proteins sold by big biotech firms. WHY IT'S HOT: Companies like Amgen (AMGN) and Genentech (DNA) rely heavily on expensive but effective protein-based therapies for diseases ranging...
Top 100 Biotechnology Companies 2004
in The Biotech Weblog, on July 14, 2005
...the world and will break into the top 10 by 2008, Wood Mackenzie analysts say. On the other hand, Genentech's operating revenue for 2004 increased 40% from 2003 to $4.62 billion.
Life Sciences...
Genetech - A Model of the New Pharmaceutical Company
in Businesspundit, on June 2, 2003
...ns for this biotech bellwether's success--young patents and a prescient CEO, to name two. But Genentech 's biggest advantage is its revolutionary method of developing and marketing drugs...